EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 95 filers reported holding EPIZYME INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $615,000 | -87.4% | 35,846 | -80.0% | 0.02% | -88.6% |
| Q3 2014 | $4,864,000 | -40.4% | 179,409 | -31.6% | 0.18% | -30.2% |
| Q2 2014 | $8,165,000 | +80.5% | 262,361 | +32.1% | 0.26% | +86.6% |
| Q1 2014 | $4,523,000 | -39.3% | 198,643 | -44.6% | 0.14% | -47.2% |
| Q4 2013 | $7,454,000 | -66.0% | 358,365 | -34.4% | 0.27% | -68.2% |
| Q3 2013 | $21,906,000 | +281.4% | 545,875 | +167.4% | 0.85% | +237.1% |
| Q2 2013 | $5,743,000 | – | 204,144 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 9,166,667 | $109,358,000 | 16.39% |
| Burrage Capital Management LLC | 1,002,528 | $11,960,000 | 9.44% |
| Foresite Capital Management III, LLC | 998,278 | $11,909,000 | 8.87% |
| MPM BioImpact LLC | 2,854,737 | $34,057,000 | 8.20% |
| Palo Alto Investors LP | 6,403,600 | $76,395,000 | 4.19% |
| Foresite Capital Management II, LLC | 862,402 | $10,288,000 | 2.24% |
| Redmile Group, LLC | 8,311,633 | $99,158,000 | 1.82% |
| Pier Capital, LLC | 574,299 | $6,851,000 | 1.00% |
| Foresite Capital Management I, LLC | 243,759 | $2,908,000 | 0.82% |
| Rock Springs Capital Management LP | 2,551,659 | $30,441,000 | 0.77% |